No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs9504059 |
chr6:4349808-4349809 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs186253224 |
chr6:4349812-4349813 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs1265207 |
chr6:4349814-4349815 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs375688969 |
chr6:4349821-4349822 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs190731494 |
chr6:4349844-4349845 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs7740780 |
chr6:4349893-4349894 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs539398584 |
chr6:4349913-4349914 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs116406729 |
chr6:4349931-4349932 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs182788223 |
chr6:4349933-4349934 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs139890267 |
chr6:4349941-4349942 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs535506877 |
chr6:4349966-4349967 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs143272682 |
chr6:4349997-4349998 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs572020650 |
chr6:4350048-4350049 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs187244199 |
chr6:4350057-4350058 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs557511259 |
chr6:4350099-4350100 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs146200754 |
chr6:4350101-4350102 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs546209893 |
chr6:4350128-4350129 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs562729440 |
chr6:4350133-4350134 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs576363957 |
chr6:4350167-4350168 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs148563320 |
chr6:4350179-4350180 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs532218081 |
chr6:4350180-4350181 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs142907268 |
chr6:4350237-4350238 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs191652984 |
chr6:4350266-4350267 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs535201610 |
chr6:4350283-4350284 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs527639385 |
chr6:4350305-4350306 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs151123508 |
chr6:4350315-4350316 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs555536228 |
chr6:4350375-4350376 |
Enhancers Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs533237892 |
chr6:4350397-4350398 |
Enhancers Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs78676338 |
chr6:4350416-4350417 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs569837399 |
chr6:4350491-4350492 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs535647162 |
chr6:4350526-4350527 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs541302210 |
chr6:4350554-4350555 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs183060490 |
chr6:4350684-4350685 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs6933759 |
chr6:4350698-4350699 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs141088632 |
chr6:4350758-4350759 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs144660831 |
chr6:4350791-4350792 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs578015196 |
chr6:4350797-4350798 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs557717371 |
chr6:4350846-4350847 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs529962126 |
chr6:4350904-4350905 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs571190765 |
chr6:4350908-4350909 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs540092960 |
chr6:4350912-4350913 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs372535415 |
chr6:4350947-4350948 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs188179424 |
chr6:4350955-4350956 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs147876746 |
chr6:4350963-4350964 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs542028792 |
chr6:4350967-4350968 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs562878097 |
chr6:4350979-4350980 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs9392588 |
chr6:4350992-4350993 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs541200025 |
chr6:4351036-4351037 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs564469625 |
chr6:4351054-4351055 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs9392589 |
chr6:4351062-4351063 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|